Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in CSTL — Castle Biosciences Inc

CIK 861177 NEW YORK, NY

Position in CSTL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,534,649
-$60,215 QoQ
Shares Held
64,346
-1.0% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 176 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 54% Shared 0% None 46%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $5,355,433,839 across 31 Diagnostics & Research names. CSTL ranks #24 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CSTL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,534,649 64,346
2026-03-31 $1,594,864 64,964
2025-12-31 $2,708,525 69,628
2025-09-30 $1,308,362 57,460
2025-06-30 $2,097,989 102,742
2025-03-31 $1,361,977 68,031
2024-12-31 $1,759,376 66,018
2024-09-30 $1,583,770 55,532
2024-06-30 $1,222,079 56,136
2024-03-31 $704,102 31,788
2023-12-31 $588,291 27,261
2023-09-30 $460,437 27,261
2023-06-30 $2,158,454 157,322
2023-03-31 $3,574,352 157,322
2022-12-31 $3,744,339 159,063
2022-09-30 $3,816,702 146,346
2022-06-30 $3,449,486 157,152
2022-03-31 $7,977,496 177,831
2021-12-31 $8,027,105 187,243
2021-09-30 $11,880,557 178,655
2021-06-30 $13,698,555 186,807
2021-03-31 $13,252,349 193,578
2020-12-31 $12,769,780 190,168
2020-09-30 $13,332,597 259,137
2020-06-30 $6,184,136 164,079
2020-03-31 $4,637,868 155,581